2<\/sup> production facility for the manufacture of cannabinoid extracts and isolates. The company also produces and distributes its own CBD natural cosmetics range. With the acquisition of Ilesol, SYNBIOTIC will be able to produce CBD isolates with the \u201cMade in EU\u201d label and distribute them through the companies of the SYNBIOTIC Group.<\/p>\n\u201cWe are thus integrating another crucial process step into our supply chain,\u201d says Daniel Kruse, Managing Director of SYNBIOTIC. \u201cThe in-house production and refinement of hemp and cannabis extracts and corresponding isolates is an enormous competitive advantage. The market for hemp extracts and CBD isolates alone is a growth market worth billions. The cosmetics industry has long since discovered hemp and CBD for itself and demand is increasing significantly. And if the EU Commission decides in favour of the numerous novel food applications next year, the demand for hemp extracts and CBD isolates in the food supplement sector will increase many times over.\u201d<\/p>\n
\u201cThe acquisition of Ilesol is therefore strategically significant news for our group of companies and investments. And for our investors and shareholders, it is the second successful takeover in four months after Bushdoctor,\u201d adds Kruse.<\/p>\n
SYNBIOTIC is ideally positioned in the CBD product segment with leading brands and, in future, Ilesol. What was missing until now was an independent production facility for refining the extracts and manufacturing isolates that was not dependent on external factors. Ilesol closes precisely this gap in the supply chain. Moreover, the additional cosmetics range from Ilesol fits perfectly into the distribution programme of SYNBIOTIC\u2019s subsidiaries Solidmind and Hempro International.<\/p>\n
\u201cAs part of the SYNBIOTIC group of companies, we can take the next steps together on a European level. As an experienced manufacturer with independent, technologically mature production processes, we will be an absolute asset to everyone involved in SYNBIOTIC in every respect,\u201d explains Sasha Bajilo, CEO and Co-Founder, Ilesol Pharmaceuticals.<\/p>\n
The declared aim of CEO Daniel Kruse is to establish SYNBIOTIC as the leading group of companies for industrial hemp and cannabis not only on the German market, but also on the European market. With the acquisitions of Bushdoctor and Ilesol, SYNBIOTIC is now also active in Austria and Croatia.<\/p>\n
\u201cThe Group\u2019s pan-European orientation is the logical step towards a strong market position throughout Europe. This not only completes our supply chain and increases our sales potential, but also increases SYNBIOTIC\u2019s importance for large, strategic investors from outside Europe,\u201d says Kruse.<\/p>\n
About Ilesol Pharmaceuticals<\/h2>\n
Ilesol Pharmaceuticals is an industrial manufacturer of cannabinoid extracts and CBD isolates specialising in cosmetic ingredients, cosmetic products and dietary supplements. The company, based in Vara\u017edin \/Croatia, has its own production facility with an area of 3,400 metres2<\/sup> and covers the entire production process.<\/p>\nAbout SYNBIOTIC<\/h2>\n
SYNBIOTIC is a listed group of companies in the hemp and cannabis sector and pursues a buy and build investment strategy focussed on the EU. The group covers the entire value chain from cultivation to production and retail \u2013 from the field to the shelf. The core businesses of the vertically integrated company are research and development, production and commercialisation of hemp, CBD and cannabis products.<\/p>\n
SYNBIOTIC has a clear strategy to further expand along the value chains of its business areas \u2013 hemp and CBD, medical cannabis and consumer cannabis.<\/p>\n<\/p><\/div>\n\n","protected":false},"excerpt":{"rendered":"
Enormous competitive advantages through cannabinoid extracts and isolates from own production. The German industrial hemp and cannabis group SYNBIOTIC SE acquires Ilesol Pharmaceuticals from Vara\u017edin\/Croatia. Ilesol has a 3,400 m2 production facility for the manufacture of cannabinoid extracts and isolates. The company also produces and distributes its own CBD natural cosmetics range. With the acquisition […]<\/p>\n","protected":false},"author":1,"featured_media":274406,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[96742,101227],"tags":[11354,101229,15827,101228],"dealstore":[],"offerexpiration":[],"class_list":["post-274405","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog","category-ilesol-news","tag-acquires","tag-ilesol","tag-pharmaceuticals","tag-synbiotic"],"yoast_head":"\n
SYNBIOTIC acquires Ilesol Pharmaceuticals! - Ilesol Pharmaceuticals - Som2ny Network<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/fivemor.com\/?p=274405\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"SYNBIOTIC acquires Ilesol Pharmaceuticals! - Ilesol Pharmaceuticals - Som2ny Network\" \/>\n<meta property=\"og:description\" content=\"Enormous competitive advantages through cannabinoid extracts and isolates from own production. The German industrial hemp and cannabis group SYNBIOTIC SE acquires Ilesol Pharmaceuticals from Vara\u017edin\/Croatia. Ilesol has a 3,400 m2 production facility for the manufacture of cannabinoid extracts and isolates. The company also produces and distributes its own CBD natural cosmetics range. With the acquisition […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/fivemor.com\/?p=274405\" \/>\n<meta property=\"og:site_name\" content=\"Som2ny Network\" \/>\n<meta property=\"article:published_time\" content=\"2025-06-05T07:03:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/fivemor.com\/wp-content\/uploads\/2025\/06\/SYNBIOTIC-acquires-Ilesol-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1075\" \/>\n\t<meta property=\"og:image:height\" content=\"419\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/fivemor.com\/?p=274405#article\",\"isPartOf\":{\"@id\":\"https:\/\/fivemor.com\/?p=274405\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\/\/fivemor.com\/#\/schema\/person\/b85e3c3dc0e1daea076524dc8810c371\"},\"headline\":\"SYNBIOTIC acquires Ilesol Pharmaceuticals! – Ilesol Pharmaceuticals\",\"datePublished\":\"2025-06-05T07:03:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/fivemor.com\/?p=274405\"},\"wordCount\":581,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/fivemor.com\/#organization\"},\"image\":{\"@id\":\"https:\/\/fivemor.com\/?p=274405#primaryimage\"},\"thumbnailUrl\":\"https:\/\/fivemor.com\/wp-content\/uploads\/2025\/06\/SYNBIOTIC-acquires-Ilesol-1.jpg\",\"keywords\":[\"Acquires\",\"Ilesol\",\"pharmaceuticals\",\"SYNBIOTIC\"],\"articleSection\":[\"Blog\",\"Ilesol News\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/fivemor.com\/?p=274405#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/fivemor.com\/?p=274405\",\"url\":\"https:\/\/fivemor.com\/?p=274405\",\"name\":\"SYNBIOTIC acquires Ilesol Pharmaceuticals! - Ilesol Pharmaceuticals - Som2ny Network\",\"isPartOf\":{\"@id\":\"https:\/\/fivemor.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/fivemor.com\/?p=274405#primaryimage\"},\"image\":{\"@id\":\"https:\/\/fivemor.com\/?p=274405#primaryimage\"},\"thumbnailUrl\":\"https:\/\/fivemor.com\/wp-content\/uploads\/2025\/06\/SYNBIOTIC-acquires-Ilesol-1.jpg\",\"datePublished\":\"2025-06-05T07:03:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/fivemor.com\/?p=274405#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/fivemor.com\/?p=274405\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/fivemor.com\/?p=274405#primaryimage\",\"url\":\"https:\/\/fivemor.com\/wp-content\/uploads\/2025\/06\/SYNBIOTIC-acquires-Ilesol-1.jpg\",\"contentUrl\":\"https:\/\/fivemor.com\/wp-content\/uploads\/2025\/06\/SYNBIOTIC-acquires-Ilesol-1.jpg\",\"width\":1075,\"height\":419},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/fivemor.com\/?p=274405#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/fivemor.com\/?bp_activities=1\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"SYNBIOTIC acquires Ilesol Pharmaceuticals! – Ilesol Pharmaceuticals\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/fivemor.com\/#website\",\"url\":\"https:\/\/fivemor.com\/\",\"name\":\"Som2ny Network\",\"description\":\"Daily Deals\",\"publisher\":{\"@id\":\"https:\/\/fivemor.com\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/fivemor.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/fivemor.com\/#organization\",\"name\":\"Som2ny Network\",\"url\":\"https:\/\/fivemor.com\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/fivemor.com\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/fivemor.com\/wp-content\/uploads\/2026\/07\/4a0953c4-logo-300x86-1.png\",\"contentUrl\":\"https:\/\/fivemor.com\/wp-content\/uploads\/2026\/07\/4a0953c4-logo-300x86-1.png\",\"width\":300,\"height\":86,\"caption\":\"Som2ny Network\"},\"image\":{\"@id\":\"https:\/\/fivemor.com\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/fivemor.com\/#\/schema\/person\/b85e3c3dc0e1daea076524dc8810c371\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/fivemor.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/729ae85bf62b9917e93538db2f2688ca?s=96&r=g&default=https%3A%2F%2Ffivemor.com%2Fwp-content%2Fplugins%2Fbuddypress-first-letter-avatar%2Fimages%2Fdefault%2F96%2Flatin_a.png\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/729ae85bf62b9917e93538db2f2688ca?s=96&r=g&default=https%3A%2F%2Ffivemor.com%2Fwp-content%2Fplugins%2Fbuddypress-first-letter-avatar%2Fimages%2Fdefault%2F96%2Flatin_a.png\",\"caption\":\"admin\"},\"sameAs\":[\"https:\/\/fivemor.com\"],\"url\":\"https:\/\/fivemor.com\/?author=1\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"SYNBIOTIC acquires Ilesol Pharmaceuticals! - Ilesol Pharmaceuticals - Som2ny Network","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/fivemor.com\/?p=274405","og_locale":"en_US","og_type":"article","og_title":"SYNBIOTIC acquires Ilesol Pharmaceuticals! - Ilesol Pharmaceuticals - Som2ny Network","og_description":"Enormous competitive advantages through cannabinoid extracts and isolates from own production. The German industrial hemp and cannabis group SYNBIOTIC SE acquires Ilesol Pharmaceuticals from Vara\u017edin\/Croatia. Ilesol has a 3,400 m2 production facility for the manufacture of cannabinoid extracts and isolates. The company also produces and distributes its own CBD natural cosmetics range. With the acquisition […]","og_url":"https:\/\/fivemor.com\/?p=274405","og_site_name":"Som2ny Network","article_published_time":"2025-06-05T07:03:00+00:00","og_image":[{"width":1075,"height":419,"url":"https:\/\/fivemor.com\/wp-content\/uploads\/2025\/06\/SYNBIOTIC-acquires-Ilesol-1.jpg","type":"image\/jpeg"}],"author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/fivemor.com\/?p=274405#article","isPartOf":{"@id":"https:\/\/fivemor.com\/?p=274405"},"author":{"name":"admin","@id":"https:\/\/fivemor.com\/#\/schema\/person\/b85e3c3dc0e1daea076524dc8810c371"},"headline":"SYNBIOTIC acquires Ilesol Pharmaceuticals! – Ilesol Pharmaceuticals","datePublished":"2025-06-05T07:03:00+00:00","mainEntityOfPage":{"@id":"https:\/\/fivemor.com\/?p=274405"},"wordCount":581,"commentCount":0,"publisher":{"@id":"https:\/\/fivemor.com\/#organization"},"image":{"@id":"https:\/\/fivemor.com\/?p=274405#primaryimage"},"thumbnailUrl":"https:\/\/fivemor.com\/wp-content\/uploads\/2025\/06\/SYNBIOTIC-acquires-Ilesol-1.jpg","keywords":["Acquires","Ilesol","pharmaceuticals","SYNBIOTIC"],"articleSection":["Blog","Ilesol News"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/fivemor.com\/?p=274405#respond"]}]},{"@type":"WebPage","@id":"https:\/\/fivemor.com\/?p=274405","url":"https:\/\/fivemor.com\/?p=274405","name":"SYNBIOTIC acquires Ilesol Pharmaceuticals! - Ilesol Pharmaceuticals - Som2ny Network","isPartOf":{"@id":"https:\/\/fivemor.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/fivemor.com\/?p=274405#primaryimage"},"image":{"@id":"https:\/\/fivemor.com\/?p=274405#primaryimage"},"thumbnailUrl":"https:\/\/fivemor.com\/wp-content\/uploads\/2025\/06\/SYNBIOTIC-acquires-Ilesol-1.jpg","datePublished":"2025-06-05T07:03:00+00:00","breadcrumb":{"@id":"https:\/\/fivemor.com\/?p=274405#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/fivemor.com\/?p=274405"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/fivemor.com\/?p=274405#primaryimage","url":"https:\/\/fivemor.com\/wp-content\/uploads\/2025\/06\/SYNBIOTIC-acquires-Ilesol-1.jpg","contentUrl":"https:\/\/fivemor.com\/wp-content\/uploads\/2025\/06\/SYNBIOTIC-acquires-Ilesol-1.jpg","width":1075,"height":419},{"@type":"BreadcrumbList","@id":"https:\/\/fivemor.com\/?p=274405#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/fivemor.com\/?bp_activities=1"},{"@type":"ListItem","position":2,"name":"SYNBIOTIC acquires Ilesol Pharmaceuticals! – Ilesol Pharmaceuticals"}]},{"@type":"WebSite","@id":"https:\/\/fivemor.com\/#website","url":"https:\/\/fivemor.com\/","name":"Som2ny Network","description":"Daily Deals","publisher":{"@id":"https:\/\/fivemor.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/fivemor.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/fivemor.com\/#organization","name":"Som2ny Network","url":"https:\/\/fivemor.com\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/fivemor.com\/#\/schema\/logo\/image\/","url":"https:\/\/fivemor.com\/wp-content\/uploads\/2026\/07\/4a0953c4-logo-300x86-1.png","contentUrl":"https:\/\/fivemor.com\/wp-content\/uploads\/2026\/07\/4a0953c4-logo-300x86-1.png","width":300,"height":86,"caption":"Som2ny Network"},"image":{"@id":"https:\/\/fivemor.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/fivemor.com\/#\/schema\/person\/b85e3c3dc0e1daea076524dc8810c371","name":"admin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/fivemor.com\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/729ae85bf62b9917e93538db2f2688ca?s=96&r=g&default=https%3A%2F%2Ffivemor.com%2Fwp-content%2Fplugins%2Fbuddypress-first-letter-avatar%2Fimages%2Fdefault%2F96%2Flatin_a.png","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/729ae85bf62b9917e93538db2f2688ca?s=96&r=g&default=https%3A%2F%2Ffivemor.com%2Fwp-content%2Fplugins%2Fbuddypress-first-letter-avatar%2Fimages%2Fdefault%2F96%2Flatin_a.png","caption":"admin"},"sameAs":["https:\/\/fivemor.com"],"url":"https:\/\/fivemor.com\/?author=1"}]}},"_links":{"self":[{"href":"https:\/\/fivemor.com\/index.php?rest_route=\/wp\/v2\/posts\/274405","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/fivemor.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/fivemor.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/fivemor.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/fivemor.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=274405"}],"version-history":[{"count":0,"href":"https:\/\/fivemor.com\/index.php?rest_route=\/wp\/v2\/posts\/274405\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/fivemor.com\/index.php?rest_route=\/wp\/v2\/media\/274406"}],"wp:attachment":[{"href":"https:\/\/fivemor.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=274405"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/fivemor.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=274405"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/fivemor.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=274405"},{"taxonomy":"dealstore","embeddable":true,"href":"https:\/\/fivemor.com\/index.php?rest_route=%2Fwp%2Fv2%2Fdealstore&post=274405"},{"taxonomy":"offerexpiration","embeddable":true,"href":"https:\/\/fivemor.com\/index.php?rest_route=%2Fwp%2Fv2%2Fofferexpiration&post=274405"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}